,17 Identifying late-stage tau accumulation may have clinical utility by increasing confidence that a set of clinical symptoms is due to AD, and furthermore may aid in treatment decisions, as individuals with more advanced tau may have lower clinical benefit following Aβ plaque removal.18 The gene discussed is MAPT; the disease is Alzheimer disease.